The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 325.50
Bid: 324.50
Ask: 325.50
Change: 0.50 (0.15%)
Spread: 1.00 (0.308%)
Open: 324.50
High: 328.50
Low: 324.50
Prev. Close: 325.00
PIN Live PriceLast checked at -
Pantheon International is an Investment Trust

To maximise capital growth by investing in a diversified portfolio of private equity funds and occasionally directly in private companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Pantheon International Plc (PIN): Returns, resilience and responsibility

9 Oct 2020 12:00

Hardman & Co Research Hardman & Co Research: Pantheon International Plc (PIN): Returns, resilience and responsibility 09-Oct-2020 / 12:00 GMT/BST


Hardman & Co Research: Returns, resilience and responsibility

The long-term messages remain unchanged from our 6 September 2019 initiation, 11.9% average annual NAV growth since 1987: i) PIP's investors get liquid access to the whole private equity (PE) market, ii) PE-backed companies, on average, deliver superior growth than quoted ones, iii) PIP is investing in the right parts of the PE market, iv) PIP benefits from being part of the Pantheon family, and v) PIP benefits from a structured asset selection process. We believe the "real" NAV is above "book" NAV and that its downturn resilience has been proven again in 2020. PIP's ESG credentials are market-leading and well-established.

Please click on the link below for the full report:

https://www.hardmanandco.com/research/corporate-research/returns-resilience-and-responsibility/

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co35 New Broad StreetLondonEC2M 1NH

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Mark Thomas

+44 20 7194 7622

 

mt@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1139966 09-Oct-2020 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
3rd Nov 20172:24 pmRNSHolding(s) in Company
3rd Nov 20171:07 pmRNSHolding(s) in Company
3rd Nov 201711:58 amRNSHolding(s) in Company
2nd Nov 201712:34 pmRNSHolding(s) in Company
1st Nov 20179:00 amRNSCompletion of Consolidation and TVR
30th Oct 20172:25 pmRNSResult of EGM and Class Meetings
20th Oct 20177:00 amRNSMonthly Performance Update
6th Oct 201712:42 pmRNSPublication of Circular and Shareholder Meetings
3rd Oct 201710:43 amRNSDirector/PDMR Shareholding
28th Sep 20175:29 pmRNSDirector/PDMR Shareholding
28th Sep 20174:14 pmRNSDirector/PDMR Shareholding
28th Sep 20177:00 amRNSProposed Share Capital Consolidation and ALN Issue
25th Sep 20177:00 amRNSMonthly Performance Update
23rd Aug 20177:00 amRNSMonthly Performance Update
8th Aug 20177:00 amRNSAnnual Report for the 11 months ended 31 May 2017
31st Jul 20177:00 amRNSMonthly Performance Update
12th Jul 20177:00 amRNSMonthly Performance Update
13th Jun 20175:42 pmRNSDirector Declaration
23rd May 20177:00 amRNSMonthly Performance Update
9th May 20172:49 pmRNSHolding(s) in Company
27th Apr 20177:00 amRNSMonthly Performance Update
18th Apr 20175:16 pmRNSChange of Accounting Reference Date
23rd Mar 20177:00 amRNSMonthly Performance Update
14th Mar 20177:00 amRNSHalf-year Report
21st Feb 20177:00 amRNSMonthly Performance Update
31st Jan 20177:00 amRNSMonthly Performance Update
21st Dec 20167:00 amRNSMonthly Performance Update
23rd Nov 20163:16 pmRNSResult of AGM
21st Nov 20167:00 amRNSMonthly Performance Update
8th Nov 20162:47 pmRNSAppointment of Non-Executive Directors
24th Oct 20167:00 amRNSMonthly Performance Update
21st Oct 20164:19 pmRNSAdditional Bank Loan Facility Agreement
28th Sep 20167:00 amRNSMonthly Performance Update
20th Sep 20167:00 amRNSAnnual Financial Report
8th Sep 20163:24 pmRNSHolding(s) in Company
8th Sep 201610:59 amRNSDirectorate Change
23rd Aug 20167:00 amRNSMonthly Performance Update
1st Aug 20167:00 amRNSMonthly Performance Update
22nd Jun 20167:00 amRNSMonthly Performance Update
20th May 20167:00 amRNSMonthly Performance Update
10th May 201610:08 amRNSHolding(s) in Company
5th May 20165:29 pmRNSHolding(s) in Company
4th May 20163:47 pmRNSDirector Declaration
21st Apr 20165:35 pmRNSTransaction in Own Shares
21st Apr 20167:00 amRNSMonthly Performance Update
15th Apr 20162:16 pmRNSHolding(s) in Company
7th Apr 20165:21 pmRNSHolding(s) in Company
21st Mar 20167:00 amRNSMonthly Performance Update
9th Mar 20164:45 pmRNSTransaction in Own Shares
9th Mar 20167:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.